01 Jan Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?
Posted at 00:00h
in
Authored by: Mocroft Amanda, Reiss Peter, Kirk Ole et al.
In: CLINICAL INFECTIOUS DISEASES 51(5), 2010, p.611-619
http://www.ncbi.nlm.nih.gov/pubmed/20645862